Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 2
2000 1
2001 2
2002 1
2003 5
2004 38
2005 71
2006 51
2007 48
2008 28
2009 20
2010 37
2011 34
2012 34
2013 30
2014 20
2015 31
2016 30
2017 92
2018 69
2019 50
2020 41
2021 37
2022 14
2023 21
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

720 results

Results by year

Filters applied: . Clear all
Page 1
No studies.
Altundag K. Altundag K. Br Dent J. 2018 Feb 23;224(4):198. doi: 10.1038/sj.bdj.2018.133. Br Dent J. 2018. PMID: 29472673 No abstract available.
Primary gastric choriocarcinoma.
Ates O, Altundag K, Gullu I. Ates O, et al. Among authors: altundag k. J BUON. 2018 Mar-Apr;23(2):534. J BUON. 2018. PMID: 29745105 No abstract available.
Pembrolizumab in Triple-Negative Breast Cancer.
Altundag K. Altundag K. N Engl J Med. 2022 Oct 13;387(15):1435-1436. doi: 10.1056/NEJMc2210919. N Engl J Med. 2022. PMID: 36239657 No abstract available.
DESTINY-Breast03 trial: some questions remain.
Altundag K. Altundag K. Lancet. 2023 May 20;401(10389):1652-1653. doi: 10.1016/S0140-6736(23)00680-3. Lancet. 2023. PMID: 37210115 No abstract available.
Cardiotoxicity of novel HER2-targeted therapies.
Sendur MA, Aksoy S, Altundag K. Sendur MA, et al. Among authors: altundag k. Curr Med Res Opin. 2013 Aug;29(8):1015-24. doi: 10.1185/03007995.2013.807232. Epub 2013 Jun 7. Curr Med Res Opin. 2013. PMID: 23692263 Review.
Pertuzumab in HER2-positive breast cancer.
Sendur MA, Aksoy S, Altundag K. Sendur MA, et al. Among authors: altundag k. Curr Med Res Opin. 2012 Oct;28(10):1709-16. doi: 10.1185/03007995.2012.728132. Epub 2012 Oct 11. Curr Med Res Opin. 2012. PMID: 22953713 Review.
Behcet's disease and breast cancer.
Altundag K. Altundag K. J BUON. 2020 Jul-Aug;25(4):2129-2130. J BUON. 2020. PMID: 33099967 Free article. No abstract available.
Temozolomide-related infections: review of the literature.
Kizilarslanoglu MC, Aksoy S, Yildirim NO, Ararat E, Sahin I, Altundag K. Kizilarslanoglu MC, et al. Among authors: altundag k. J BUON. 2011 Jul-Sep;16(3):547-50. J BUON. 2011. PMID: 22006764 Review.
720 results